Triple Marker with Graph, 2nd Trimester in New Delhi
Understanding Triple Marker with Graph, 2nd Trimester in New Delhi
What is Triple Marker with Graph, 2nd Trimester in New Delhi?
Triple Marker with Graph is a maternal screening test that provides useful information about pregnancy. This test is valid between 14-22 weeks gestation (Ideal 15-20 weeks) of pregnancy to assess and screen the fetus for certain birth defects. The test measures the level of three biochemical markers in the blood, Alpha-fetoprotein (AFP), Human chorionic gonadotropin (HCG), and Estriol, and along with USG findings, calculates the risk of certain genetic defects in the fetus.
The triple marker is a blood test that helps to screen for certain genetic disorders like Down's syndrome, Edward's syndrome, and open neural tube defects.
In case the risk assessment gives an increased chance of genetic defects in the fetus, confirmatory tests are required like Chorionic villus biopsy Amniocentesis or NIPT. Sometimes a detailed ultrasound is also done to examine the fetal skull and spine.
The screening test is a statistical analysis of a patient’s data and depends upon the patient's age, weight, number of fetuses, IVF, weeks of pregnancy, etc., and the results are illustrated in the form of a graph in the test report. The approximate detection rate varies from 55-65% with a false positive rate of approx 5%. Confirmation is mandatory by other methods.
NOTE: It has been acknowledged that using different software for statistical analysis could lead to dissimilar risk calculations.
What does Triple Marker with Graph, 2nd Trimester measure?
Contains 2 testsMaternal Screening tests measure risk only. They don’t tell you for sure if the fetus has a genetic condition. A positive result means the fetus is at a higher risk for that disorder than the general population. A negative result means the fetus is at a lower risk of having that disorder than the general population.
HCG Beta Total Quantitative, Maternal
An HCG Beta Total Quantitative, Maternal test measures the levels of human chorionic gonadotropin (hCG) hormone in the blood. hCG is released in the blood during pregnancy and can be detected as early as 10 days after conception. The levels of this hormone gradually rise every 2 to 3 days (or 48 to 72 hours) and peak around 8 to 11 weeks after conception. After reaching the peak, the hCG levels decrease and remain steady for the rest of the pregnancy.
Know more about HCG Beta Total Quantitative, Maternal
Unconjugated Estriol
Unconjugated Estriol is a type of estrogen hormone produced by the placenta. Abnormal levels may suggest an increased risk of the developing baby being born with chromosomal abnormalities.
Know more about Unconjugated Estriol